Tired of CPAP? Discover a Non-Invasive OSA Solution.

A Widespread and Serious Condition

Obstructive Sleep Apnea is a life-threatening respiratory condition affecting 1 in 8 people, significantly reducing quality of life and longevity.

The US market for OSA treatments is substantial, estimated at $8.1 billion and growing, yet current solutions have major drawbacks.

The Problem with CPAP

While CPAP (Continuous Positive Airway Pressure) can be life-saving, it requires sleeping with a mask and hose indefinitely. Discomfort, noise, and inconvenience lead many patients to abandon treatment – about 40% of devices are discarded, representing billions in wasted healthcare spending annually.

Would you settle for CPAP for life, or would you prefer a non-invasive cure?

Illustration of CPAP Use

Anatomical diagram showing airway fat

It's Often About Localized Fat

The leading cause of OSA is excessive fat deposits in the mouth, throat, and surrounding areas, obstructing the airway during sleep.

Research using MRI has shown that reducing tongue fat significantly reduces the severity of sleep apnea (AHI).

Targeting and reducing this specific fat could potentially cure OSA for a majority of patients, eliminating the need for lifelong devices like CPAP.

The challenge: How to reduce this internal fat effectively and non-invasively, without requiring overall weight loss?

Targeted Fat Reduction, No Weight Loss Required

Alesis OSA1 is an FDA-Cleared, prescription-only medical device designed to help patients achieve significant localized fat reduction in the areas contributing to OSA – without dieting or general weight loss.

Developed with patented technology (11 utility patents in 31 countries), Alesis OSA1 represents a breakthrough in OSA treatment.

Compared to corrective surgery, implanted devices, CPAP masks, or oral appliances, Alesis OSA1 offers a unique, non-invasive alternative.

Alesis OSA1 Device in Use

Conceptual "Before/After"

Key Advantages:

• Non-Invasive: No surgery, needles, or incisions involved.
• No Masks or Devices While Sleeping: Addresses the root cause, aiming to eliminate the need for nightly appliances like CPAP.
• Comfortable & Convenient: Treatments are performed in-office with no discomfort or downtime required afterwards.
• Safe & Proven Technology: FDA-Cleared device based on technology with a decade-long safety record.
• Targets the Cause: Directly reduces the excess fat linked to airway obstruction in many OSA patients.
• Potentially Curative: Aims to provide a long-term solution, not just symptom management.

Multi-site clinical trials and MRI studies are ongoing to further document treatment efficacy and optimize protocols for OSA.